AI
DMK

Atom Investors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Atom Investors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,074
Closed -$46K – 350
2021
Q4 		$46K Buy
1,074
+267
+33% +$16.7K 0.01% 249
2021
Q3 		$55K Buy
+807
New +$59.1K ﹤0.01% 296

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Atom Investors's DMK Position: Q1 2022 in Review

Atom Investors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2022, closing a stake of 1,074 shares — an estimated $46K sold.

Atom Investors first reported a position in DMK in Q3 2021 and held it in 2 quarters. The position peaked at $55K in Q3 2021. 46 funds tracked by Wall St. Rank hold DMK as of Q1 2022.

  • Atom Investors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
  • Atom Investors sold 1,074 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2022, an estimated $46K.
  • Atom Investors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2021 and held it in 2 quarters.
  • Atom Investors's DMK Pharmaceuticals Corporation Common Stock position peaked at $55K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2022.

Based on Atom Investors's 13F filing for Q1 2022, filed 16 May 2022.